Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation | MicrobiomeTrials← Back to trialsNCT03805477
Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2019-03-20Est. Completion: 2026-07-29
Enrollment target: 20 participants Locations- King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
- Clinic of Hematology, University Hospital Basel, Basel, Switzerland
- Clinic of Respiratory Medicine, University Hospital Basel, Basel, Switzerland
Other microbiome trials you might be interested in
Graft Vs Host DiseaseAcute-graft-versus-host DiseaseChronic Graft-versus-host-disease
This study is about determining if an aerobic and resistance exercise intervention is feasible in patients diagnosed wit…
Boston, United StatesEst. completion Feb 28, 2027
Graft-versus-host Disease (GVHD)
The purpose of this study is to assess Tacrolimus/Methotrexate/Ruxolitinib versus Post-Transplant Cyclophosphamide/Tacro…
Palo Alto, United StatesEst. completion Jan 17, 2031